Repair gene O6-methylguanine-DNA methyltransferase is controlled by SP1 and up-regulated by glucocorticoids, but not by temozolomide and radiation-Reference-Cited by-同舟云学术

Repair gene O6-methylguanine-DNA methyltransferase is controlled by SP1 and up-regulated by glucocorticoids, but not by temozolomide and radiation

Published:2018-01 Issue:2 Volume:144 Page:139-151
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:J. Neurochem.

Author:

Aasland Dorthe¹,Reich Thomas R.¹,Tomicic Maja T.¹,Switzeny Olivier J.¹,Kaina Bernd¹,Christmann Markus¹^ORCID

Affiliation:

1. Department of Toxicology; University Medical Center Mainz; Mainz Germany

Funder

Deutsche Krebshilfe

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jnc.14262/fullpdf

Reference55 articles.

1. Activation of human O6-methylguanine-DNA methyltransferase gene by glucocorticoid hormone;Biswas;Oncogene,1999

2. p53-Mediated down-regulation of the human DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) via interaction with Sp1 transcription factor;Bocangel;Anticancer Res.,2009

3. Regulation of expression of the DNA repair gene O6-methylguanine-DNA methyltransferase via protein kinase C-mediated signaling;Boldogh;Can. Res.,1998

4. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas;Brandsma;Lancet Oncol.,2008

5. Activation of stress-responsive promoters by ionizing radiation for deployment in targeted gene therapy;Chastel;DNA Repair,2004

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circadian regulation of MGMT expression and promoter methylation underlies daily rhythms in TMZ sensitivity in glioblastoma;Journal of Neuro-Oncology;2024-01-26

2. DDX5 (p68) orchestrates β-catenin, RelA and SP1 mediated MGMT gene expression in human colon cancer cells: Implication in TMZ chemoresistance;Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms;2023-12

3. Temozolomide, Procarbazine and Nitrosoureas in the Therapy of Malignant Gliomas: Update of Mechanisms, Drug Resistance and Therapeutic Implications;Journal of Clinical Medicine;2023-11-30

4. Drug resistance in glioblastoma: from chemo- to immunotherapy;Cancer Drug Resistance;2023-10-11

5. A Systematic Review of High Impact CpG Sites and Regions for MGMT Methylation in Glioblastoma [A Systematic Review of MGMT Methylation in GBM];2023-10-11